ANL 33.60 Increased By ▲ 0.50 (1.51%)
ASC 14.53 Increased By ▲ 0.18 (1.25%)
ASL 24.88 Increased By ▲ 0.40 (1.63%)
AVN 91.39 Decreased By ▼ -1.11 (-1.2%)
BOP 9.10 Increased By ▲ 0.04 (0.44%)
BYCO 9.80 Increased By ▲ 0.10 (1.03%)
DGKC 133.25 Increased By ▲ 1.06 (0.8%)
EPCL 50.28 Increased By ▲ 0.18 (0.36%)
FCCL 24.40 Increased By ▲ 0.10 (0.41%)
FFBL 24.29 Decreased By ▼ -0.11 (-0.45%)
FFL 15.12 Increased By ▲ 0.10 (0.67%)
HASCOL 10.60 Increased By ▲ 0.04 (0.38%)
HUBC 86.02 Increased By ▲ 0.92 (1.08%)
HUMNL 6.80 Increased By ▲ 0.05 (0.74%)
JSCL 25.70 Increased By ▲ 0.45 (1.78%)
KAPCO 41.00 Increased By ▲ 2.25 (5.81%)
KEL 3.96 Decreased By ▼ -0.02 (-0.5%)
LOTCHEM 14.54 Increased By ▲ 0.11 (0.76%)
MLCF 46.10 Increased By ▲ 0.22 (0.48%)
PAEL 37.02 Increased By ▲ 0.32 (0.87%)
PIBTL 11.38 Decreased By ▼ -0.05 (-0.44%)
POWER 10.25 Increased By ▲ 0.10 (0.99%)
PPL 90.50 Increased By ▲ 0.80 (0.89%)
PRL 26.50 Increased By ▲ 0.25 (0.95%)
PTC 8.66 Increased By ▲ 0.06 (0.7%)
SILK 1.35 No Change ▼ 0.00 (0%)
SNGP 41.30 Decreased By ▼ -0.10 (-0.24%)
TRG 144.80 Increased By ▲ 1.70 (1.19%)
UNITY 30.10 Increased By ▲ 0.31 (1.04%)
WTL 1.40 Decreased By ▼ -0.02 (-1.41%)
BR100 4,925 Increased By ▲ 36.63 (0.75%)
BR30 25,546 Increased By ▲ 270.19 (1.07%)
KSE100 45,536 Increased By ▲ 257.29 (0.57%)
KSE30 19,055 Increased By ▲ 156.4 (0.83%)
World

Coronavirus triggered 'anti-tumour response' in 61-year-old patient: Study

  • A new study revealed that a 61-year-old man, suffering from renal failure and progressive lymphadenopathy, contracted the coronavirus, and over the span of a few months it was observed that it had an anti-tumour response.
  • Shortly after his diagnosis, he was admitted to the hospital with breathlessness and wheezing, and was diagnosed with the coronavirus. After 11-days of medical care, he was discharged to recuperate at home, with no additional immuno-chemotherapy being administered.
Updated 21 Jan 2021
Source: British Society for Haematology (2020).
Source: British Society for Haematology (2020).

A new study revealed that a 61-year-old man, suffering from renal failure and progressive lymphadenopathy, contracted the coronavirus, and over the span of a few months it was observed that it had an anti-tumour response.

The study was carried out by the British Society for Haematology, and hypothesised that the coronavirus infection triggered an anti-tumour response in the patient, and subsequently led to an unprecedented disintegration of the tumour cells.

Prior to contracting the virus, the patient was suffering from end-stage renal failure, progressive lymphadenopathy and severe weight loss, and had already faced a failed renal transplant three years prior.

Shortly after his diagnosis, he was admitted to the hospital with breathlessness and wheezing, and was diagnosed with the coronavirus. After 11-days of medical care, he was discharged to recuperate at home, with no additional immuno-chemotherapy being administered.